부산대학교 도서관

Lewin, Jeremy ; Malone, Eoghan ; Al-Ezzi, Esmail; Fasih, Samir; Pedersen, Pernille; Accardi, Sarah; Gupta, Abha; Abdul Razak, Albiruni

In European Journal of Cancer February 2021 144:360-367

Salah, Samer ; Lewin, Jeremy ; Amir, Eitan ; Abdul Razak, Albiruni

In Cancer Treatment Reviews September 2018 69:1-10

Shimizu, Toshio; Powderly, John; Abdul Razak, Albiruni; LoRusso, Patricia; Miller, Kathy D.; Kao, Steven; Kongpachith, Sarah; Tribouley, Catherine; Graham, Michelle; Stoll, Brian; Patel, Maulik; Sahtout, Mohammad; Blaney, Martha; Leibman, Rachel; Golan, Talia; Tolcher, Anthony

Frontiers in Oncology; 2025, p1-18, 18p

Shimizu T; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan.; Department of New Experimental Therapeutics and International Cancer New Drug Development Center, Kansai Medical University Hospital, Osaka, Japan.; Powderly J; Carolina BioOncology Institute, Huntersville, NC, United States.; Abdul Razak A; Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre, Toronto, ON, Canada.; LoRusso P; Yale Cancer Center, Yale University, New Haven, CT, United States.; Miller KD; Department of Medicine, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN, United States.; Kao S; Department of Medical Oncology, Chris O'Brien Lifehouse, Sydney, NSW, Australia.; Kongpachith S; AbbVie Bay Area, South San Francisco, CA, United States.; Tribouley C; AbbVie Bay Area, South San Francisco, CA, United States.; Graham M; AbbVie Bay Area, South San Francisco, CA, United States.; Stoll B; AbbVie Bay Area, South San Francisco, CA, United States.; Patel M; AbbVie Bay Area, South San Francisco, CA, United States.; Sahtout M; AbbVie Bay Area, South San Francisco, CA, United States.; Blaney M; AbbVie Bay Area, South San Francisco, CA, United States.; Leibman R; AbbVie Bay Area, South San Francisco, CA, United States.; Golan T; Institute of Oncology, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.; Oncology Institute, Sheba Medical Center at Tel-Hashomer, Tel Aviv University, Tel Aviv, Israel.; Tolcher A; New Experimental Therapeutics (NEXT) Oncology, San Antonio, TX, United States.

Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

Al‐Ezzi, Esmail; Gounder, Mrinal; Watson, Geoffrey; Mazzocca, Alessandro; D'Angelo, Sandra P.; Bravetti, Julie; Wang, Hongwei; Abdul Razak, Albiruni; Vincenzi, Bruno

Oncologist; Apr2021, Vol. 26 Issue 4, pe710-e714, 5p, 1 Color Photograph, 1 Chart

Zer, Alona; Prince, Rebecca M.; Amir, Eitan; Razak, Albiruni Abdul; Abdul Razak, Albiruni

Journal of Clinical Oncology. 5/1/2016, Vol. 34 Issue 13, p1469-1475. 7p.

Chiu, Joanne; Chan, Kelvin; Chen, Eric; Siu, Lillian; Abdul Razak, Albiruni

Investigational New Drugs; Aug2015, Vol. 33 Issue 4, p895-900, 6p

Kummar, Shivaani; Abdul Razak, Albiruni; Laurie, Scott; Kell, Sariah; Glatt, Dylan; Majeed, Sophia R.; Rasco, Drew

CANCER RESEARCH; APR 15 2023, 83 8, 2p. Supplement: S

Watson GA; Division of Medical Oncology and Hematology, University Health Network, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.; Sanz-Garcia E; Division of Medical Oncology and Hematology, University Health Network, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.; Zhang WJ; Division of Medical Oncology and Hematology, University Health Network, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.; Liu ZA; Biostatistics, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada.; University of Toronto Dalla Lana School of Public Health, Toronto, Ontario, Canada.; Yang SC; Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.; Wang B; Laboratory Medicine and Pathobiology, University Health Network, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.; Liu S; Immunology, University of Toronto, Toronto, Ontario, Canada.; Kubli S; Immunology, University of Toronto, Toronto, Ontario, Canada.; Berman H; Laboratory Medicine and Pathobiology, University Health Network, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.; Pfister T; Laboratory Medicine and Pathobiology, University Health Network, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.; Genta S; Division of Medical Oncology and Hematology, University Health Network, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.; Spreafico A; Division of Medical Oncology and Hematology, University Health Network, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.; Hansen AR; Division of Medical Oncology and Hematology, University Health Network, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.; Bedard PL; Division of Medical Oncology and Hematology, University Health Network, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.; Lheureux S; Division of Medical Oncology and Hematology, University Health Network, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.; Abdul Razak A; Division of Medical Oncology and Hematology, University Health Network, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.; Cescon D; Division of Medical Oncology and Hematology, University Health Network, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.; Butler MO; Division of Medical Oncology and Hematology, University Health Network, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.; Xu W; Biostatistics, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada.; Mak TW; Immunology, University of Toronto, Toronto, Ontario, Canada.; Siu LL; Division of Medical Oncology and Hematology, University Health Network, Princess Margaret Cancer Centre, Toronto, Ontario, Canada lillian.siu@uhn.ca.; Chen E; Division of Medical Oncology and Hematology, University Health Network, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.

Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

Taylor K; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Loo Yau H; Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.; Chakravarthy A; Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.; Genetics and Epigenetics, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Wang B; Immunology, University of Toronto, Toronto, Ontario, Canada.; Immuno-Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.; Shen SY; Genetics and Epigenetics, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Ettayebi I; Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.; Ishak CA; Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.; Genetics and Epigenetics, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Bedard PL; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Abdul Razak A; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; R Hansen A; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Spreafico A; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Cescon D; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Butler MO; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Oza AM; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Lheureux S; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Stjepanovic N; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Van As B; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Boross-Harmer S; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Wang L; Biostatistics, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Pugh TJ; Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.; Genomics, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.; Ohashi PS; Immunology, University of Toronto, Toronto, Ontario, Canada.; Immuno-Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.; Siu LL; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada ddecarv@uhnresearch.ca lillian.siu@uhn.ca.; De Carvalho DD; Medical Biophysics, University of Toronto, Toronto, Ontario, Canada ddecarv@uhnresearch.ca lillian.siu@uhn.ca.; Genetics and Epigenetics, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.

Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE